This is a Validated Antibody Database (VAD) review about human chromogranin A, based on 67 published articles (read how Labome selects the articles), using chromogranin A antibody in all methods. It is aimed to help Labome visitors find the most suited chromogranin A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
chromogranin A synonym: CGA

Abcam
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1e, 4b, 4c
Abcam chromogranin A antibody (Abcam, 15160) was used in immunohistochemistry on mouse samples at 1:100 (fig 1e, 4b, 4c). Cell Mol Gastroenterol Hepatol (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 1e
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry on mouse samples (fig 1e). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s3b
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry - paraffin section on mouse samples (fig s3b). Mucosal Immunol (2021) ncbi
domestic rabbit monoclonal (EP1030Y)
  • immunohistochemistry; mouse; loading ...; fig 3
Abcam chromogranin A antibody (Abcam, EP1030Y) was used in immunohistochemistry on mouse samples (fig 3). BMC Cancer (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 1i
Abcam chromogranin A antibody (Abcam, Ab15160) was used in immunohistochemistry on mouse samples (fig 1i). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1o
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1o). Dis Model Mech (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s2c
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry - paraffin section on mouse samples (fig s2c). Oncotarget (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3a
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 3c
  • immunocytochemistry; human; loading ...; fig 3b
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam chromogranin A antibody (Abcam, ab15160) was used in western blot on mouse samples at 1:1000 (fig 3a), in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3c), in immunocytochemistry on human samples (fig 3b) and in western blot on human samples at 1:1000 (fig 3a). Oncol Lett (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig s4c
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry on mouse samples at 1:200 (fig s4c). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • flow cytometry; human; 1:500; loading ...; fig e7f
Abcam chromogranin A antibody (Abcam, ab15160) was used in flow cytometry on human samples at 1:500 (fig e7f). Nature (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 7b
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5e
Abcam chromogranin A antibody (Abcam, Ab15160) was used in immunohistochemistry - paraffin section on human samples (fig 7b) and in immunohistochemistry - paraffin section on mouse samples (fig 5e). Cell (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig s2a
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry on mouse samples (fig s2a). PLoS Biol (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 1e
In order to evaluate the distribution of CGA immunoreactive cells in serial sections of human fetal prostate specimens, Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1e). J Biol Chem (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; fig s2
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s2). Nature (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:4000; fig s2
In order to characterize the enhancement of tumorigenicity and stemness of intestinal progenitors due to a high-fat diet, Abcam chromogranin A antibody (Abcam, 15160) was used in immunohistochemistry - paraffin section on mouse samples at 1:4000 (fig s2). Nature (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 2
Abcam chromogranin A antibody (Abcam, ab15160) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Sci Rep (2016) ncbi
Invitrogen
domestic rabbit monoclonal (SP12)
  • western blot; rat; loading ...; fig 8c
Invitrogen chromogranin A antibody (ThermoFisher, MA5-14536) was used in western blot on rat samples (fig 8c). Nat Commun (2020) ncbi
mouse monoclonal (LK2H10)
  • immunohistochemistry - paraffin section; human; fig 7a
In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Invitrogen chromogranin A antibody (Thermo Scientific, MA5-13096) was used in immunohistochemistry - paraffin section on human samples (fig 7a). Sci Rep (2017) ncbi
mouse monoclonal (LK2H10)
  • western blot; human; loading ...; fig 1c
In order to elucidate the regulation of PHF8 and KDM3A during neuroendocrine differentiation and castration-resistant prostate cancer, Invitrogen chromogranin A antibody (Thermo Fisher, MS-324-P0) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (SP12)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1e
In order to find prognostic factors for gastric neuroendocrine carcinoma, Invitrogen chromogranin A antibody (Thermo Fisher, SP12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1e). Contemp Oncol (Pozn) (2016) ncbi
domestic rabbit monoclonal (SP12)
  • immunohistochemistry; human; 1:50
In order to discuss the characteristics of Ewing's Sarcoma family of tumors of urinary bladder, Invitrogen chromogranin A antibody (Thermo Scientific, SP12) was used in immunohistochemistry on human samples at 1:50. Balkan Med J (2016) ncbi
mouse monoclonal (LK2H10)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 2
In order to examine the role of ACTG2 in small intestinal neuroendocrine tumorigenesis, Invitrogen chromogranin A antibody (NeoMarkers, LK2H10) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2). BMC Endocr Disord (2016) ncbi
mouse monoclonal (LK2H10)
  • immunohistochemistry - frozen section; human; 1:800; fig 5
In order to test interactions between enterochromaffin cells, Intestinal stem cells, and small intestinal neuroendocrine tumors, Invitrogen chromogranin A antibody (Thermo Scientific, MS-324-P) was used in immunohistochemistry - frozen section on human samples at 1:800 (fig 5). Gastroenterology (2016) ncbi
mouse monoclonal (LK2H10)
  • immunohistochemistry; human; 1:150; fig 1
In order to examine lymphatic capillaries in human islets histologically, Invitrogen chromogranin A antibody (Thermo Fisher Scientific, LK2H10) was used in immunohistochemistry on human samples at 1:150 (fig 1). Diabetes (2016) ncbi
mouse monoclonal (LK2H10)
  • immunohistochemistry - paraffin section; human; fig 1
In order to describe the immune cell infiltrates found in pituitary adenomas, Invitrogen chromogranin A antibody (Thermo Scientific, LK2H10+PHES) was used in immunohistochemistry - paraffin section on human samples (fig 1). Endocr Pathol (2015) ncbi
mouse monoclonal (LK2H10)
  • immunohistochemistry - paraffin section; guinea pig; 1:800
Invitrogen chromogranin A antibody (Lab Vision Corp, LK2H10) was used in immunohistochemistry - paraffin section on guinea pig samples at 1:800. Tissue Cell (2015) ncbi
mouse monoclonal (LK2H10)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to report the clinicopathological and immunohistochemical features of goblet cell carcinoid, Invitrogen chromogranin A antibody (Zymed, LK2H10) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Int J Surg Pathol (2010) ncbi
Santa Cruz Biotechnology
mouse monoclonal
  • immunohistochemistry; human; 1:200; loading ...; fig 1b
Santa Cruz Biotechnology chromogranin A antibody (Santa Cruz, sc-393941) was used in immunohistochemistry on human samples at 1:200 (fig 1b). Cell Rep (2022) ncbi
mouse monoclonal
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1e
Santa Cruz Biotechnology chromogranin A antibody (Santa Cruz Biotechnology, sc-393941) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1e). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal
  • western blot; mouse; 1:200; fig 5e
Santa Cruz Biotechnology chromogranin A antibody (Santa Cruz, sc-393941) was used in western blot on mouse samples at 1:200 (fig 5e). Nat Commun (2019) ncbi
mouse monoclonal (F-12)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s3c
Santa Cruz Biotechnology chromogranin A antibody (Santa, sc-376827) was used in immunohistochemistry - frozen section on mouse samples (fig s3c). Nat Commun (2018) ncbi
mouse monoclonal
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3c
Santa Cruz Biotechnology chromogranin A antibody (Santa Cruz, sc-393941) was used in immunohistochemistry on mouse samples at 1:500 (fig 3c). Nat Commun (2016) ncbi
mouse monoclonal (LK2H10)
  • western blot; human; 1:1000; fig s3
Santa Cruz Biotechnology chromogranin A antibody (Santa Cruz, LK2H10) was used in western blot on human samples at 1:1000 (fig s3). J Clin Endocrinol Metab (2016) ncbi
OriGene
mouse monoclonal (OTI1G3)
  • immunocytochemistry; human; 1:100; loading ...; fig 1f
OriGene chromogranin A antibody (Beijing Zhongshan Golden Bridge Biotech, TA506095) was used in immunocytochemistry on human samples at 1:100 (fig 1f). J Cancer (2022) ncbi
Novus Biologicals
domestic rabbit polyclonal (9F9.F9)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 5d
Novus Biologicals chromogranin A antibody (Novus, NB120-15160SS) was used in immunohistochemistry on mouse samples at 1:500 (fig 5d). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (CGA/414)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 1f
Novus Biologicals chromogranin A antibody (Novus Biologicals, NBP2-29428) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 1f). J Neurosci (2018) ncbi
GeneTex
  • immunohistochemistry - paraffin section; human; 1:2000; tbl 1
  • immunohistochemistry - paraffin section; mouse; 1:2000; tbl 1
In order to discover a potential source of serum autotaxin in men by analyzing enteroendocrine cells, GeneTex chromogranin A antibody (GeneTex, GTX 15160) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (tbl 1) and in immunohistochemistry - paraffin section on mouse samples at 1:2000 (tbl 1). Biochim Biophys Acta (2016) ncbi
Dako
mouse monoclonal (DAK-A3)
  • immunohistochemistry; human; 1:200; fig s5b
Dako chromogranin A antibody (DAKO, M0869) was used in immunohistochemistry on human samples at 1:200 (fig s5b). iScience (2022) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 1
Dako chromogranin A antibody (Dako, M0869) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). ESMO Open (2022) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2
Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). BMC Cancer (2019) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 3s1f
Dako chromogranin A antibody (Dako, M086901) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 3s1f). elife (2019) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3c
Dako chromogranin A antibody (Dako, M869) was used in immunohistochemistry - paraffin section on human samples (fig 3c). Science (2018) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry; human; loading ...
Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry on human samples . Nature (2017) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; rat; 1:1000; loading ...; fig 3a
Dako chromogranin A antibody (Dako, M869) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 (fig 3a). Int J Mol Med (2016) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...
In order to analyze small-cell lung cancer samples for CD274 mutations, Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:500. Clin Cancer Res (2017) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Nat Med (2016) ncbi
mouse monoclonal (DAK-A3)
  • immunocytochemistry; human; 1:300; fig 1
Dako chromogranin A antibody (DakoCytomation, DAK-A3) was used in immunocytochemistry on human samples at 1:300 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry; human; 1:500; loading ...; tbl 1
Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry on human samples at 1:500 (tbl 1). Pathol Int (2016) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...
In order to assess the relationship between the results of the octreotide test and somatostatin receptor 2 expression in insulinoma patients to predict insulinomas in Japanese patients, Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:150. Endocr J (2016) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to discuss the use of a theranostic combination to treat pediatric patients with refractory neuroblastoma, Dako chromogranin A antibody (DakoCytomation, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). J Pediatr Hematol Oncol (2016) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry; human; 1:5000
Dako chromogranin A antibody (DAKO Corporation, DAK-A3) was used in immunohistochemistry on human samples at 1:5000. Virchows Arch (2015) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry; human
In order to show that nuclear DKK-1 is a predictive biomarker of chemoresistance in colorectal cancer, Dako chromogranin A antibody (Dako, M0869) was used in immunohistochemistry on human samples . Oncotarget (2015) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:200
Dako chromogranin A antibody (DakoCytomation, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Am J Surg Pathol (2015) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:400
Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:400. J Clin Pathol (2015) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:100
Dako chromogranin A antibody (DAKO, DAK-A3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Endocr Pathol (2014) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:50
  • immunocytochemistry; human; 1:50
In order to report on the development and characterization of a human pancreatic beta-cell line that is conditionally immortalized, Dako chromogranin A antibody (DakoCytomation, M0869) was used in immunohistochemistry - paraffin section on human samples at 1:50 and in immunocytochemistry on human samples at 1:50. J Clin Invest (2014) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human; 1:4000
Dako chromogranin A antibody (Dako, M0869) was used in immunohistochemistry - paraffin section on human samples at 1:4000. Exp Mol Pathol (2014) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry; human
In order to compare the diagnostic efficacies of cell block method and conventional smear method for bile cytology, Dako chromogranin A antibody (DAKO, DAK-A3) was used in immunohistochemistry on human samples . Dig Endosc (2013) ncbi
mouse monoclonal (DAK-A3)
  • immunohistochemistry - paraffin section; human
In order to investigate the polypoid PEComa in the gastrointestinal tract, Dako chromogranin A antibody (Dako, DAK-A3) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2009) ncbi
Leica Biosystems
monoclonal (5H7)
  • immunohistochemistry; human; 0.84 ug/ml; loading ...; fig 3o
Leica Biosystems chromogranin A antibody (Leica, 5H7) was used in immunohistochemistry on human samples at 0.84 ug/ml (fig 3o). Nat Commun (2021) ncbi
monoclonal (5H7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2b
Leica Biosystems chromogranin A antibody (Leica Biosystems/Novocastra, 5H7) was used in immunohistochemistry - paraffin section on human samples (fig 2b). Int J Mol Sci (2020) ncbi
mouse monoclonal (5H7)
  • immunohistochemistry; human
In order to characterize and present the features observed in sixteen cases of solid pseudopapillary neoplasm of the pancreas, Leica Biosystems chromogranin A antibody (Novocastra, NCL-L-CHROM-430) was used in immunohistochemistry on human samples . Kaohsiung J Med Sci (2016) ncbi
monoclonal (5H7)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 1c
Leica Biosystems chromogranin A antibody (Novocastra, PA0431) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1c). Oncol Lett (2016) ncbi
monoclonal (5H7)
  • immunohistochemistry - paraffin section; human
In order to describe an unusual case of a recurrent dural neoplasm, Leica Biosystems chromogranin A antibody (Novocastra, 5H7) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
monoclonal (5H7)
  • immunohistochemistry; human; 1:100
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Leica Biosystems chromogranin A antibody (Novocastra, 5H7) was used in immunohistochemistry on human samples at 1:100. Arch Dermatol Res (2015) ncbi
monoclonal (5H7)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
Leica Biosystems chromogranin A antibody (Novocastra, 5H7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Pathol Res Pract (2014) ncbi
mouse monoclonal (5H7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 4
In order to characterize two patients with multinodular and vacuolating neuronal tumors, Leica Biosystems chromogranin A antibody (Novocastra, NCL-CHROM-430) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4). Acta Neuropathol Commun (2014) ncbi
Articles Reviewed
  1. Duan S, Sawyer T, Sontz R, Wieland B, Diaz A, Merchant J. GFAP-directed Inactivation of Men1 Exploits Glial Cell Plasticity in Favor of Neuroendocrine Reprogramming. Cell Mol Gastroenterol Hepatol. 2022;14:1025-1051 pubmed publisher
  2. Koide T, Koyanagi Aoi M, Uehara K, Kakeji Y, Aoi T. CDX2-induced intestinal metaplasia in human gastric organoids derived from induced pluripotent stem cells. iScience. 2022;25:104314 pubmed publisher
  3. Yan S, Conley J, Reilly A, Stull N, Abhyankar S, Ericsson A, et al. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion. Cell Rep. 2022;38:110179 pubmed publisher
  4. Zhao Y, Wang Q, Zeng Y, Xie Y, Zhou J. Gastrin/CCK-B Receptor Signaling Promotes Cell Invasion and Metastasis by Upregulating MMP-2 and VEGF Expression in Gastric Cancer. J Cancer. 2022;13:134-145 pubmed publisher
  5. Simbolo M, Centonze G, Ali G, Garzone G, Taormina S, Sabella G, et al. Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities. ESMO Open. 2022;7:100308 pubmed publisher
  6. Risbridger G, Clark A, Porter L, Toivanen R, Bakshi A, Lister N, et al. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. Nat Commun. 2021;12:5049 pubmed publisher
  7. Das B, Okamoto K, Rabalais J, Young J, Barrett K, Sivagnanam M. Aberrant Epithelial Differentiation Contributes to Pathogenesis in a Murine Model of Congenital Tufting Enteropathy. Cell Mol Gastroenterol Hepatol. 2021;12:1353-1371 pubmed publisher
  8. Krausová A, Buresova P, Sarnova L, Oyman Eyrilmez G, Skarda J, Wohl P, et al. Plectin ensures intestinal epithelial integrity and protects colon against colitis. Mucosal Immunol. 2021;14:691-702 pubmed publisher
  9. Hofving T, Elias E, Rehammar A, Inge L, Altiparmak G, Persson M, et al. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors. BMC Cancer. 2021;21:101 pubmed publisher
  10. Quintero M, Liu S, Xia Y, Huang Y, Zou Y, Li G, et al. Cdk5rap3 is essential for intestinal Paneth cell development and maintenance. Cell Death Dis. 2021;12:131 pubmed publisher
  11. Lin L, Petralia R, Lake R, Wang Y, Hoffman D. A novel structure associated with aging is augmented in the DPP6-KO mouse brain. Acta Neuropathol Commun. 2020;8:197 pubmed publisher
  12. Thorsen A, Khamis D, Kemp R, Colombé M, Lourenco F, Morrissey E, et al. Heterogeneity in clone dynamics within and adjacent to intestinal tumours identified by Dre-mediated lineage tracing. Dis Model Mech. 2021;14: pubmed publisher
  13. Xu E, Vosburgh E, Wong C, Tang L, Notterman D. Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice. Oncotarget. 2020;11:2718-2739 pubmed publisher
  14. Dong Y, Li Y, Liu R, Li Y, Zhang H, Liu H, et al. Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A. Oncol Lett. 2020;19:2223-2230 pubmed publisher
  15. Kővári B, Turkevi Nagy S, Báthori Á, Fekete Z, Krenacs L. Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors. Int J Mol Sci. 2020;21: pubmed publisher
  16. Santos M, Anderson C, Neschen S, Zumbrennen Bullough K, Romney S, Kahle Stephan M, et al. Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification. Nat Commun. 2020;11:296 pubmed publisher
  17. Xing T, Benderman L, Sabu S, Parker J, Yang J, Lu Q, et al. Tight Junction Protein Claudin-7 Is Essential for Intestinal Epithelial Stem Cell Self-Renewal and Differentiation. Cell Mol Gastroenterol Hepatol. 2020;9:641-659 pubmed publisher
  18. Fusco P, Parisatto B, Rampazzo E, Persano L, Frasson C, Di Meglio A, et al. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours. BMC Cancer. 2019;19:970 pubmed publisher
  19. Yung T, Poon F, Liang M, Coquenlorge S, McGaugh E, Hui C, et al. Sufu- and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals. Nat Commun. 2019;10:4647 pubmed publisher
  20. Veres A, Faust A, Bushnell H, Engquist E, Kenty J, Harb G, et al. Charting cellular identity during human in vitro β-cell differentiation. Nature. 2019;569:368-373 pubmed publisher
  21. Lodge E, Santambrogio A, Russell J, Xekouki P, Jacques T, Johnson R, et al. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade. elife. 2019;8: pubmed publisher
  22. Fenderico N, van Scherpenzeel R, Goldflam M, Proverbio D, Jordens I, Kralj T, et al. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells. Nat Commun. 2019;10:365 pubmed publisher
  23. Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
  24. Koren E, Yosefzon Y, Ankawa R, Soteriou D, Jacob A, Nevelsky A, et al. ARTS mediates apoptosis and regeneration of the intestinal stem cell niche. Nat Commun. 2018;9:4582 pubmed publisher
  25. Park J, Lee J, Sheu K, Wang L, Balanis N, Nguyen K, et al. Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 2018;362:91-95 pubmed publisher
  26. Lyons J, Ghazi P, Starchenko A, Tovaglieri A, Baldwin K, Poulin E, et al. The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile. PLoS Biol. 2018;16:e2002417 pubmed publisher
  27. Jiang Z, Rajamanickam S, Justice N. Local Corticotropin-Releasing Factor Signaling in the Hypothalamic Paraventricular Nucleus. J Neurosci. 2018;38:1874-1890 pubmed publisher
  28. Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
  29. Scarpa A, Chang D, Nones K, Corbo V, Patch A, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543:65-71 pubmed publisher
  30. Szczyrba J, Niesen A, Wagner M, Wandernoth P, Aumüller G, Wennemuth G. Neuroendocrine Cells of the Prostate Derive from the Neural Crest. J Biol Chem. 2017;292:2021-2031 pubmed publisher
  31. El Salhy M, Mazzawi T, Umezawa K, Gilja O. Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis. Int J Mol Med. 2016;38:1743-1751 pubmed publisher
  32. Hinckelmann M, Virlogeux A, Niehage C, Poujol C, Choquet D, Hoflack B, et al. Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport. Nat Commun. 2016;7:13233 pubmed publisher
  33. Maina P, Shao P, Liu Q, Fazli L, Tyler S, Nasir M, et al. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer. Oncotarget. 2016;7:75585-75602 pubmed publisher
  34. Deng Y, Chen X, Ye Y, Shi X, Zhu K, Huang L, et al. Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas. Contemp Oncol (Pozn). 2016;20:311-9 pubmed publisher
  35. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel A, et al. Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 2017;23:1220-1226 pubmed publisher
  36. Tonyali S, Yazici S, Yeşilırmak A, Ergen A. The Ewing's Sarcoma Family of Tumors of Urinary Bladder: A Case Report and Review of the Literature. Balkan Med J. 2016;33:462-6 pubmed publisher
  37. Fotouhi O, Kjellin H, Larsson C, Hashemi J, Barriuso J, Juhlin C, et al. Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors. J Clin Endocrinol Metab. 2016;101:3616-3627 pubmed
  38. Ugras N, Yerci O, Coşkun S, Ocakoglu G, Sarkut P, Dündar H. Retrospective analysis of clinicopathological features of solid pseudopapillary neoplasm of the pancreas. Kaohsiung J Med Sci. 2016;32:356-61 pubmed publisher
  39. Edfeldt K, Hellman P, Westin G, Stalberg P. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis. BMC Endocr Disord. 2016;16:19 pubmed publisher
  40. Sei Y, Feng J, Zhao X, Forbes J, Tang D, Nagashima K, et al. Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors. Gastroenterology. 2016;151:140-51 pubmed publisher
  41. Ravindran R, Loebbermann J, Nakaya H, Khan N, Ma H, Gama L, et al. The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature. 2016;531:523-527 pubmed publisher
  42. Beyaz S, Mana M, Roper J, Kedrin D, Saadatpour A, Hong S, et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature. 2016;531:53-8 pubmed publisher
  43. Kumar A, Coleman I, Morrissey C, Zhang X, True L, Gulati R, et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat Med. 2016;22:369-78 pubmed publisher
  44. Ji C, Zhou M, Gan W, Zheng J, Yan X, Guo H. Advanced prostatic ductal carcinoma in a patient with a long survival time following a total pelvis exenteration: A case report. Oncol Lett. 2016;11:1509-1511 pubmed
  45. Gradiz R, Silva H, Carvalho L, Botelho M, Mota Pinto A. MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648 pubmed publisher
  46. Nakagawa A, Adams C, Huang Y, Hamarneh S, Liu W, Von Alt K, et al. Selective and reversible suppression of intestinal stem cell differentiation by pharmacological inhibition of BET bromodomains. Sci Rep. 2016;6:20390 pubmed publisher
  47. Korsgren E, Korsgren O. An Apparent Deficiency of Lymphatic Capillaries in the Islets of Langerhans in the Human Pancreas. Diabetes. 2016;65:1004-8 pubmed publisher
  48. Bolier R, Tolenaars D, Kremer A, Saris J, Pares A, Verheij J, et al. Enteroendocrine cells are a potential source of serum autotaxin in men. Biochim Biophys Acta. 2016;1862:696-704 pubmed publisher
  49. Yamaguchi M, Komori T, Nakata Y, Yagishita A, Morino M, Isozaki E. Multinodular and vacuolating neuronal tumor affecting amygdala and hippocampus: A quasi-tumor?. Pathol Int. 2016;66:34-41 pubmed publisher
  50. Nakamura A, Mitsuhashi T, Takano Y, Miyoshi H, Kameda H, Nomoto H, et al. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas. Endocr J. 2016;63:135-42 pubmed publisher
  51. Kong G, Hofman M, Murray W, Wilson S, Wood P, Downie P, et al. Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma. J Pediatr Hematol Oncol. 2016;38:87-96 pubmed publisher
  52. Lu J, Adam B, Jack A, Lam A, Broad R, Chik C. Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas. Endocr Pathol. 2015;26:263-72 pubmed publisher
  53. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  54. Hussein O, Elgamal D, Elgayar S. Structure of the secretory cells of male and female adult guinea pigs Harderian gland. Tissue Cell. 2015;47:323-35 pubmed publisher
  55. Miracco C, Toscano M, Butorano M, Baldino G, Tacchini D, Barone A, et al. Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma. Hum Pathol. 2015;46:1050-6 pubmed publisher
  56. Aguilera Ã, González Sancho J, Zazo S, Rincón R, Fernández A, Tapia O, et al. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer. Oncotarget. 2015;6:5903-17 pubmed
  57. Kim J, Kim M, Kim K, Song K, Lee S, Hwang D, et al. Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors. Am J Surg Pathol. 2015;39:592-601 pubmed publisher
  58. Projetti F, Serrano E, Vergez S, Bissainthe A, Delisle M, Uro Coste E. Is neuroendocrine differentiation useful to discriminate primary sinonasal intestinal-type adenocarcinomas from metastatic colorectal adenocarcinomas?. J Clin Pathol. 2015;68:79-82 pubmed publisher
  59. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  60. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  61. Changchien Y, Bocskai P, Kovacs I, Hargitai Z, Kollár S, Torok M. Pleomorphic hyalinizing angiectatic tumor of soft parts: case report with unusual ganglion-like cells and review of the literature. Pathol Res Pract. 2014;210:1146-51 pubmed publisher
  62. Scharfmann R, Pechberty S, Hazhouz Y, von Bülow M, Bricout Neveu E, Grenier Godard M, et al. Development of a conditionally immortalized human pancreatic ? cell line. J Clin Invest. 2014;124:2087-98 pubmed publisher
  63. Sørdal Ø, Qvigstad G, Nordrum I, Sandvik A, Gustafsson B, Waldum H. The PAS positive material in gastric cancer cells of signet ring type is not mucin. Exp Mol Pathol. 2014;96:274-8 pubmed publisher
  64. Bodi I, Curran O, Selway R, Elwes R, Burrone J, Laxton R, et al. Two cases of multinodular and vacuolating neuronal tumour. Acta Neuropathol Commun. 2014;2:7 pubmed publisher
  65. Noda Y, Fujita N, Kobayashi G, Ito K, Horaguchi J, Hashimoto S, et al. Prospective randomized controlled study comparing cell block method and conventional smear method for bile cytology. Dig Endosc. 2013;25:444-52 pubmed publisher
  66. Yong Jiang -, Huawei Liu -, Hu Long -, Yingying Yang -, Dianying Liao -, Xiuhui Zhang -. Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest china. Int J Surg Pathol. 2010;18:488-92 pubmed publisher
  67. Ryan P, Nguyen V, Gholoum S, Carpineta L, Abish S, Ahmed N, et al. Polypoid PEComa in the rectum of a 15-year-old girl: case report and review of PEComa in the gastrointestinal tract. Am J Surg Pathol. 2009;33:475-82 pubmed publisher